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Abstract
Background: Core outcome sets (COS) should be relevant to key stakeholders and widely applicable and usable.
Ideally, they are developed for international use to allow optimal data synthesis from trials. Electronic Delphi surveys
are commonly used to facilitate global participation; however, this has limitations. It is common for these surveys to
be conducted in a single language potentially excluding those not fluent in that tongue. The aim of this study is to
summarise current approaches for optimising international participation in Delphi studies and make
recommendations for future practice.
Methods: A comprehensive literature review of current approaches to translating Delphi surveys for COS
development was undertaken. A standardised methodology adapted from international guidance derived from 12
major sets of translation guidelines in the field of outcome reporting was developed. As a case study, this was
applied to a COS project for surgical trials in gastric cancer to translate a Delphi survey into 7 target languages from
regions active in gastric cancer research.
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Results: Three hundred thirty-two abstracts were screened and four studies addressing COS development in
rheumatoid and osteoarthritis, vascular malformations and polypharmacy were eligible for inclusion. There was
wide variation in methodological approaches to translation, including the number of forward translations, the
inclusion of back translation, the employment of cognitive debriefing and how discrepancies and disagreements
were handled. Important considerations were identified during the development of the gastric cancer survey
including establishing translation groups, timelines, understanding financial implications, strategies to maximise
recruitment and regulatory approvals. The methodological approach to translating the Delphi surveys was easily
reproducible by local collaborators and resulted in an additional 637 participants to the 315 recruited to complete
the source language survey. Ninety-nine per cent of patients and 97% of healthcare professionals from non-English-
speaking regions used translated surveys.
Conclusion: Consideration of the issues described will improve planning by other COS developers and can be used
to widen international participation from both patients and healthcare professionals.
Introduction
A core outcome set (COS) is an agreed standardised set
of outcomes that should be measured and reported, as a
minimum, in all clinical trials in specific areas of health
or healthcare [1]. COS should be relevant to key stake-
holders and widely applicable such that researchers are
encouraged and willing to incorporate them in trials.
Approaches to improve the relevance of COS can take
many forms, including involving stakeholders with lived
experience of the condition or intervention in question.
Many COS developers are using Delphi surveys during
stages to prioritise potentially important outcomes [2]. A
Delphi survey is a method of seeking consensus and asks
participants to score items in terms of importance, usu-
ally using a Likert-type scale, across multiple survey
rounds. In subsequent rounds, participants can reflect
on their score and the ratings of others before being
given the opportunity to change their scores if they wish.
Using an online platform to undertake a Delphi survey
enables overseas stakeholders to participate more readily
in this process. Such broad participation can give COS
greater validity across different geographical regions and
consequently make them more likely to be used in fu-
ture trials regardless of the location where trials are
undertaken. Unless COS are widely used in trials within
the same research field, the challenge of inconsistent
outcome reporting will persist [3].
Most research groups developing ‘international’ Del-
phi surveys have restricted themselves to their native
language (usually, but not exclusively, English). This
approach is less resource intensive than translating
the survey into multiple languages and overcomes is-
sues with ambiguity or changes in meaning—a recog-
nised challenge with translation [4]. However, these
methodological challenges are not insurmountable,
and some COS developers are translating Delphi sur-
veys to minimise the risk of excluding important
opinion from those not fluent in the study’s primary
language.
The GASTROS study (GAstric Cancer Surgery TRials
Reported Outcome Standardisation) aims to develop an
international COS for surgical trials in gastric cancer [5].
The scope and design of the GASTROS study have been
previously detailed [5]. In summary, following a system-
atic review of randomised control trials [3] and a series
of in-depth patient interviews [6], a long-list of poten-
tially important outcomes was rationalised into a list of
56 outcomes. Following a consultative exercise with key
stakeholders, these 56 outcomes were presented to pa-
tients and healthcare professionals in a two-round,
multi-language Delphi survey. Currently, there is no
standardised method of translating Delphi surveys for
use in the development of international COS. This paper
aimed to address this need by using GASTROS as a case
study to implement a methodological approach to trans-
lation developed from international consensus guidelines
in the field of outcome reporting [4].
Objectives
The objectives of this paper include:
1. To describe the current methodological approaches
used by COS developers in the translation of Delphi
surveys;
2. To outline a pragmatic, robust and replicable
approach to translating Delphi surveys for use in
COS development; and
3. To outline important logistical considerations in
preparation for an international Delphi survey.
Methods
Assessing current approaches to translating Delphi
surveys (methodology)
To gain an understanding of current translation ap-
proaches for multi-language Delphi surveys, a comprehen-
sive literature review of the COMET database was
undertaken [7]. The COMET database is a comprehensive
registry which (as of 03/09/2019) contained 337 published
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and 280 ongoing COS respectively dating back from 1981.
The database is kept up to date through annual systematic
reviews of scientific databases (using MEDLINE via OVID
and SCOPUS); automated alerts from MEDLINE via
OVID, SCOPUS and Google Scholar; and direct submis-
sions from COS developers [2].
Search strategy and inclusion criteria
The COMET database enables users to search for terms
within the ‘title’, ‘abstract’ or ‘author names’ categories.
Searches can be restricted according to health area, tar-
get population, methods, stakeholder involvement, study
type and publication year. A broad search for the terms
‘international’, ‘language’ or ‘translat$’ in the title and ab-
stract was undertaken with no other restrictions.
Studies included in our review were those that used a
multi-language Delphi survey in the development of
their respective COS. Only publications from completed
studies were included—COS methodology is a relatively
new research field and so planned approaches may not
accurately reflect the final methodology used. The
COMET database may contain several different refer-
ences to COS development for the same project. Any re-
lated publications were consolidated and handled as a
single COS study.
Corresponding authors were contacted and asked to
participate in a questionnaire examining various aspects
of their respective methodological approaches (Add-
itional file 1). The questionnaire focussed on how items
presented in the Delphi surveys were translated and how
discrepancies and conflict were resolved. Responses were
received from the corresponding authors of all studies
identified and combined with data from the respective
publications.
Approach to translating the GASTROS Delphi survey
One of the principal aims of translating the Delphi sur-
vey in the development of COS is to include the opin-
ions of stakeholders who are not fluent in the source
language. With respect to the GASTROS study, this was
especially important given that the highest incidence of
gastric cancer exists outside of English-speaking coun-
tries, in the Far East, Central and South America and
Southern Europe.
In developing our approach to translate the survey, the
study management group was keen to ensure that it was
both methodologically sound yet pragmatic such that it
could be easily reproduced by multiple international col-
laborators within a relatively short period of time.
In 1999, the ISPOR-TCA group (The Professional So-
ciety for Health Economics and Outcomes Research –
Translation and Cultural Adaptation group) was formed
to discuss and develop guidelines for translating patient-
reported outcome measures. The group highlighted
inconsistencies with previous methodologies and no-
menclature in this field and sought to address these by
developing guidance setting out ‘principles of good prac-
tice’ [4]. These principles were derived from 12 major
sets of translation guidelines from the following groups:
 American Association of Orthopaedic Surgeons
(AAOS)
 Association of Test Publishers
 EORTC group
 Euro QoL group
 Evidence: Clinical and Pharmaceutical Research
 FACIT group
 Health Outcomes group (HOG)
 Health Utilities Inc. (HUInc)
 International Quality of Life Assessment (IQOLA)
group
 Kidney Disease Quality of Life (KDQOL)
 Medical Outcomes Trust (MOT)
 World Health Organization
Other consensus guidelines have been developed for
translating surveys. The Survey Research Centre (SRC)
guidelines provide broader consideration of the transla-
tion process and describe practical support from expert
contributors’ experience of different survey types [8].
There is much cross-over between the two guidelines.
Given the focus of our work was primarily outcome-
related translation, the principles as set out by the
ISPOR-TCA group formed the basis of our method-
ology, with references made to the SRC guidance and
some pragmatic amendments which are explained in
further detail below.
Eligibility criteria for target languages
The target languages were chosen to enable increased
recruitment from regions with a significant incidence of
gastric cancer and experience of research activity within
this field. The source survey was developed in English
and translated into seven target languages (Simplified
Chinese, Dutch, German, Italian, European Portuguese,
European Spanish and Turkish). By facilitating participa-
tion from these regions, we aimed to improve the valid-
ity of our COS such that it would be more likely to be
used by researchers in future trials.
Results
Comprehensive literature review of previous translation
approaches
Three hundred forty-six records were identified from
the COMET database from which four studies (sum-
marised in Table 1) were deemed eligible for inclusion
in the comprehensive literature review. The process
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through which these were identified is summarised in
Fig. 1.
General approaches to translation currently in use
All 4 COS groups summarised their approach to trans-
lating surveys with one providing a reference to their
methodology and another referring to the methodology
described by the OMERACT group at a COS develop-
ment meeting [8, 13]. In addition to forward transla-
tions, three groups undertook a backward translation of
the survey from the target to the source language. The
number of forward and backward translations differed in
each study. Two studies undertook a single forward
translation whilst the others undertook two and three.
One group used no backward translations and one study
undertook a single backward translation whilst the other
two undertook two backward translations. The charac-
teristics of those involved in the translation processes
also differed amongst the groups (Fig. 2); no paid trans-
lation services were employed, and all translations were
undertaken by healthcare professionals or lay translators.
Discrepancies and harmonisation
All four groups described an approach to managing dis-
crepancies in translations. Two groups reported that dis-
crepancies were discussed within the ‘research group’
until consensus was reached, whilst the remaining two
referred to individuals outside of the ‘research group’
who were fluent in the target language to resolve any
language issues.
Cognitive debriefing
Three groups described undertaking an exercise to test
alternative wording and check understandability, inter-
pretation and cultural relevance of the proposed Delphi
survey in the target language. Using interviews, they
studied patients/relatives and health professionals’ inter-
pretation of the translations to examine face validity (the
degree to which the survey appears effective in terms of
its stated aims). Two of these involved patients and/or
their relatives whilst the third was based on the opinion
of healthcare professionals alone.
Results from the GASTROS study
The GASTROS study was able to recruit 952 eligible
participants (445 surgeons, 268 patients, 239 nurses) in
the first round of the Delphi survey, with 315 partici-
pants using the English-language version and 637 using
one of the seven other language versions (Table 2).
Sixty-two per cent (166/268) of patients used translated
surveys compared to 69% (471/684) of healthcare profes-
sionals (62% of surgeons and 82% of nurses).
Development of translation approach
Below, we describe ten steps involved in translating the
Delphi survey used in the development of a COS for sur-
gical trials in gastric cancer. The full rationale for each
step, and the risks of omitting them, is described in de-
tail in the ISPOR-TCA guidance; we have stated the ra-
tionale for the steps below (particularly in relation to
pragmatic deviations) where we believed it was necessary
to do so.
Additional file 2 details the instructions which were
provided to each international collaborator responsible
for leading the translation process in their respective
country. These outlined which files required translation,
how the translation should be undertaken and by whom.
Step 1: Preparation
a. Cognitive debriefing:
i. Cognitive debriefing describes a process which
aims to identify issues with comprehensibility of
key concepts and understanding amongst
potential participants. As previously stated, we
presented survey participants with 56 outcomes
which had been rationalised following a process
that had identified a long-list of potentially im-
portant outcomes from a systematic review and
Table 1 Studies using multi-language Delphi surveys in the development of international COS
Condition/group Original
language




Hip and knee osteoarthritis
OMERACT-OARSI [9]
English Italian and Spanish 426 2 (0.5%)
Medication review in multi-morbid older
patients with polypharmacy
OPERAM [10]
French Dutch, German, English 150 118 (79%)
Idiopathic inflammatory myopathy
OMERACT [11]
English Swedish, Dutch and Korean 500 120 (24%)
Vascular malformations
OVAMA Group [12]
English Dutch 301 72 (24%)
Gastric cancer
GASTROS study
English Chinese, Dutch, German, Italian,
Portuguese, Spanish, Turkish
952 637 (66%)
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in-depth patient interviews. The rationalisation
process from the long-list to the 56 survey items
involved key stakeholders (members of the
GASTROS study group, surgeons, oncology
nurses and patients) who also ensured that the
outcomes were accompanied with plain English-
language explanations that could be understood
by all participants including patients. A further
consultative exercise with an English-speaking
patient-group was held to ensure that the mean-
ing of each outcome, in addition to other
survey-related files, was clearly understood.
Undertaking this work prior to translation was
essential as it minimised the possibility of am-
biguous meanings which could result in a
mistranslation.
b. Preparing documents for translation
i. Four documents were needed to run the Delphi
survey: a participant information sheet and
three further files which were required to set up
the web-based survey. We used DelphiManager
3.0 platform, developed and maintained by the
COMET Initiative (http://www.comet-initiative.
org/), to undertake the Delphi survey (see the
‘Important considerations’ section). A compre-
hensive overview of the platform’s functionality
and capability can be found at https://www.
comet-initiative.org/delphimanager/. The three
files included:
1. File 1 (Additional file 3): an Excel file
containing details of each outcome,
accompanying meaning and the ‘outcome


































No Delphi = 104
Not international = 5
International, single-
language only = 84
Other article = 9
Studies included in review 
(n = 4)
Records after related publications from the 
same COS consolidated.
(n = 332)
Fig. 1 Flow diagram demonstrating which studies were included in the systematic review
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Table 2 Uptake of translated Delphi surveys in non-English-speaking regions
Regional
language
Patients (n = 268) Surgeons (n = 445) Nurses (n = 239)










Chinese 60 (97%) 2 (3%) 109 (97%) 3 (3%) 109 (100%) 0 (0%)
Dutch 5 (100%) 0 (0%) 22 (100%) 0 (0%) 10 (100%) 0 (0%)
German 4 (100%) 0 (0%) 10 (100%) 0 (0%) – –
Italian 57 (100%) 0 (0%) 57 (95%) 3 (5%) 12 (100%) 0 (0%)
Portuguese 1 (100%) 0 (0%) 28 (88%) 4 (12%) 8 (100%) 0 (0%)
Spanish – – 33 (94%) 2 (6%) 0 (100%) 0 (0%)










Total 166 (99%) 2 (1%) 276 (96%) 13 (4%) 195 (100%) 0 (0%)
Percentages reported refer to the proportion of participants from the respective region within each stakeholder group
a‘Other language’ refers to regions where English was not the first language, but where the survey was not translated
Independent from the study team
 Healthcare professional
 Target language is their first language
 Reside in the country of target language
 Fluent in the source language
 Previous experience of medical or patient-
reported outcome translation
Number of studies
Independent from the study team
 Healthcare professional
 Non healthcare professional
They have not seen the source document 
which was ‘forward translated’




Fig. 2 a Characteristics of translators undertaking forward translation(s). b Characteristics of translators undertaking backward translation(s)
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area’ under which the outcome was
categorised [14].
2. File 2: user-defined text: a file containing
text specific to our surveys (in this case the
GASTROS Delphi survey).
3. File 3: static text: a file containing text
common to all Delphi surveys which was
used in the setting up process by the
DelphiManager team.
ii. Preparation for round 2 of the Delphi survey:
additional translations were required to support
the second round of the survey. These included:
1. Outcomes identified by participants in
round 1 as being important to consider that
were not identified from the systematic
review or patient interviews.
2. Legends and terms required to produce
charts which were presented to survey
participants in round 2.
3. Comments and feedback from study
participants.
iii. Following round 2 of the survey:
1. Participants who changed their scores
between rounds were given the opportunity
to provide their reasons for doing so.
2. Participants were also given the opportunity
to provide further comments after
completing the survey.
c. Understanding which methodological approaches to
employ
Due to the resources required for different
methodologies, we opted for two approaches to
translation. Our rationale for applying each
approach is described below:
1. ‘Two forward, one back translation’; the
terms ‘forward’ and ‘backward’ refer to the
direction of translation between the source
and target languages, with forward referring
to a translation from the source language
and backward referring to a translation
from the target language back to the source
language. This approach was the most
comprehensive and labour intensive as it
required a further nine steps (below) before
a final file version was agreed. Following
discussion amongst the study management
team, it was deemed content which could
alter the meaning of the outcomes being
presented and ultimately influence how the
overall aims of the survey was received and
understood by participants (file 1, file 2 and
additional outcomes identified by
participants in round 1) underwent this
approach. The steps involved in this process
are described in greater detail in points 2 to
10.
2. ‘One forward, dual independent proofreading’;
file 3 consisted primarily of short instructional
phrases (e.g. ‘click here’, ‘register’ and ‘next
page’) which were necessary for the
functionality of the survey. As these terms
would not materially influence the
comprehension of the survey’s purpose or
outcomes presented within it, a simplified, less
resource-intensive approach was adopted.
This file underwent a single forward transla-
tion followed by two independent proof-
readings by translators who compared the
translated and source files for accuracy and
quality. Any corrections or amendments were
undertaken through discussion between the
translator and proof-readers. This approach
was also adopted for the translation of partici-
pant comments, feedback and reasons for
changing scores between round 1 and round
2.
d. Setting up translation teams
To support the translation work, an international
working group (IWG) was established (see the
‘Important considerations’ section). Each
collaborator within the IWG was responsible for
overseeing a team which would undertake the
translation and ensuring that the key concepts of
the study were appropriately communicated. The
translation process was supported by the GAST
ROS study Chief Investigator (BA) if any
clarifications were required. The characteristics of
individuals involved in this process are described
in greater detail in Additional file 2. In summary,
each team was made up of an IWG lead, two
forward translators and a single backward
translator.
e. Developing instructions for translations
Setting out the methodology a priori in a clear
and structured document ensured that
collaborators and their teams understood what
would be required of them at each stage of the
translation. These instructions included ongoing
responsibilities prior to and following future
rounds of the Delphi survey. This was essential
given that one of our primary aims was to ensure
that our approach was easily replicable. Figure 3
is a flow diagram which details these stages and
the order in which they were to be undertaken.
Feedback from the IWG was positive in response
to these instructions with collaborators reporting
that the document enabled them to undertake the
translation process efficiently.
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f. Quality assurance
IWG collaborators were asked to provide
documented evidence for each step of the
translation process. These could then be reviewed
by the study management team as required.
Step 2: Forward translation Two independent forward
translations by individuals who were native speakers of
the target language were undertaken. Culture is a pri-
mary determinant of language and therefore native
speakers have advantages with language abilities com-
pared to second-language speakers. Having two inde-
pendent forward translations enables detection of errors
and divergent interpretations that could otherwise lead
to bias.
Step 3: Reconciliation There are several approaches
which can be used to reconcile the forward translations.
We opted to use the ‘in-country’ IWG collaborator who
was also involved in cognitive debriefing and piloting of
the survey as this was pragmatic and would not require
the identification of further individuals to undertake this
step. No issues arose from the reconciliation process;
however, had further clarifications been required, they
would have been directed to the Chief Investigator (CI).
Step 4: Back translation The issue of whether ‘back
translation’ is required is one on which there is disagree-
ment; the ISPOR-TCA guidance states that ‘back trans-
lation’ is necessary, whilst the Survey Research Centre
guidance suggests that it is not. COS developers may
therefore be justified in omitting steps 4 and 5 of our
approach. This should however be done after careful
consideration as the importance of back translation may
depend on the type of outcomes that are being trans-
lated. It is possible that certain outcomes are conceptu-
ally alien between cultures or geographical regions and
undergoing an added step to reduce the risk of mistrans-
lation is warranted. In the field of patient-reported out-
come measurement (PROM), it is common for
questionnaires to undergo translations (for use in inter-
national trials). The methods required for PROM trans-
lation are rigorous and include back translation [15].
Whilst it may be argued that less rigorous methods
could be used in Delphi surveys for COS, to ensure opti-
mal face validity of items, the same standards are
recommended.
We opted to undertake a single back translation to
provide quality control of the forward translations.
Whilst the ISPOR-TCA guidance suggests that this
should be undertaken by individuals who are native
speakers of the source language (i.e. English), we found
it challenging to identify seven native English speakers
who were also fluent in the required target languages
and had an understanding of outcome reporting without
referring to a professional service (paid professionals
with expertise in translation). We opted to ensure that
back-translators were fluent in English and independent
from the forward translators.
Step 5: Back translation review This step is important
as it ensures that the cross-cultural adaptation needs of
the translation are met. Cross-cultural adaptation en-
sures that the imprinted knowledge, attitudes, values,
Fig. 3 Step-by-step translation process for multi-language Delphi surveys
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perceptions and behaviours of different regions are
accounted for in the understanding of the terms being
translated. Without it, there is a risk of that a mistransla-
tion or omission would remain in the translation. This
was undertaken by the CI in combination with the IWG
collaborator by comparing the back translation to the
source document. No significant discrepancies between
the source and back-translated files were identified
across any of the translations.
Step 6: Harmonisation across different languages
There is no agreed method to how harmonisation across
different translations should be enforced; many ap-
proaches omit this step. However, our group opted to
ensure harmonisation between each language at each
step of the process. This was undertaken by the CI. We
did not encounter significant differences between trans-
lations. An example of a minor change that was made
across surveys was the term ‘last round scores’ which in
the context of the survey meant ‘previous round scores’.
Some teams translated this as ‘the final round scores’
which had to be altered to ensure all versions contained
the same meaning.
Step 7: Cognitive debriefing of the translation Follow-
ing harmonisation across translations, all survey versions
were built using the DelphiManager platform (see the
‘Important considerations’ section). A further cognitive
debriefing exercise was undertaken by asking IWG col-
laborators and their translation teams to complete a
pilot version of the survey to identify grammatical or
stylistic errors and check understandability,
interpretation and cultural relevance of instructions and
outcomes within the survey.
Step 8: Review of cognitive debriefing results and
finalisation There were no issues highlighted with com-
prehensibility or understanding. Spelling mistakes and
minor grammatical errors (e.g. pronouns ‘you’ formal
and informal) were altered.
Step 9: Proofreading IWG collaborators were once
again asked to examine the survey and ensure that any
issues highlighted in the previous steps had been ad-
dressed. No further changes were identified in any of the
language versions by this stage.
Step 10: Final report and ‘start of survey’ The ISPOR-
TCA group guidance recommends that a report should
be produced detailing the methodological approach for
translation and rationale for each step. The final report
for translations undertaken for the GASTROS study is
represented by this paper. The complete survey pre-
sented in round 1 of the Delphi survey is presented in
Additional file 4.
Important considerations
Whilst applying the described approach to translating
the GASTROS Delphi survey, several key issues were
identified that are summarised in Table 3 and described
in greater detail below. These should be considered
alongside the translation work to maximise recruitment.
We describe the rationale for each consideration and the
Table 3 Nine key considerations for COS developers undertaking multi-language Delphi surveys
1 International working group To ensure that study and its aims are promoted in regions from where the study team wish to target
recruitment.
2 Patient and public involvement To ensure that the patient perspective is represented.
3 Who should undertake the translation
work?
Deciding whether to employ professionally paid services or identify clinically trained individuals to
undertake the translations.
4 Milestone and timeline planning Providing a pre-agreed timetable for translation work and checks ahead of recruitment to the Delphi
survey.
5 Recruitment and retention targets Planning how long to keep Delphi survey rounds open to ensure an appropriate number of participants
have been recruited.
6 Paper and Internet-based survey
versions
Giving stakeholders without easy access to the Internet an opportunity to participate in the study.
7 Measures to maximise recruitment Dissemination strategy
Local recruitment
Support from stakeholder group and research networks
Collaborations
Personalised e-mails
Social media and multimedia
8 Ethical approval Identifying what type of approvals are required as these vary between regions.
9 Financial planning Ensuring that a robust plan for resource allocation is made in advance.
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potential risks of not applying these steps (where
applicable).
International working group The GASTROS study is a
collaborative international initiative which sought to at-
tract global representation within the study group. Moti-
vated, research-active collaborators from countries with
a significant incidence of gastric cancer were approached
to form an IWG. Individuals signed a ‘terms of refer-
ence’ document which outlined the benefits of their in-
volvement in addition to the following responsibilities:
 To form a local team and oversee the translation of
the Delphi survey (where applicable)
 To drive recruitment locally, regionally, nationally
and internationally through organisations and
personal networks
 To garner and develop links specifically with patient
groups who would be able to participate in
advertising the Delphi survey
 To identify the need and apply for relevant local
ethical and regulatory approvals
The IWG was made up of collaborators from the fol-
lowing countries:
 Brazil












Ensuring the IWG was set up early maximised our
ability to develop translations in a timely manner and re-
cruit evenly across all stakeholder groups from a broad
range of countries.
Patient and public involvement A Study Advisory
Group (SAG) separate to the IWG formed part of the
management structure of the wider GASTROS study.
The SAG was made up of key stakeholder representa-
tives including patients. The group provided advice on
the methodology of the study and general delivery of the
study against its stated objectives and ensured that the
viewpoints of all stakeholder groups were considered. In
addition, patient groups (see the ‘Acknowledgements’
section) were vitally important in reviewing and piloting
the translated surveys prior to recruitment to the Delphi.
These groups were also instrumental in recruiting pa-
tients (see below).
Who should undertake the translation work? The
GASTROS study management group opted to set up
local translation teams made up of healthcare profes-
sionals who met the rigorous criteria as set out by the
ISPOR-TCA group. An alternative approach would have
been to employ a professional translation service to
undertake this work. One of the benefits of professional
services is the ability to complete the translations in a
relatively short period of time, in addition to developing
an unlimited number of translations which may have re-
sulted in wider participation in the Delphi survey. The
main disadvantage to this approach is cost. Quotes from
three different professional translation services (all famil-
iar with the ISPOR-TCA guidance) were requested to
support rounds 1 and 2 of the survey. In April 2018, the
estimated costs were in the region of 3200GBP–
4000GBP per language. All translations for rounds 1 and
2 of the survey would be finalised within 5 and 2 weeks
respectively. Due to the financial limitations of undertak-
ing the survey in 7 languages, we did not pursue this
option.
Milestone and timeline planning A summary of the
resulting timelines involved in producing all versions of
the survey using our approach to translation is provided
in Table 4. Setting aside enough time for the translation
process is of paramount importance, particularly if COS
developers are seeking to translate their surveys into
more than one language. Some of the translation steps
required all language versions to have reached the same
stage prior to moving onto the next stage. For example,
all initial translations had to have been completed before
harmonisation across surveys could be achieved. With-
out this, we were unable to ask collaborators and their
teams to pilot their respective surveys. Furthermore, we
chose to open recruitment to all language versions sim-
ultaneously and so all translations needed to have been
fully completed before participants could complete their
surveys. This was also the case for the second survey
round. The impact of ethical approval applications on
timelines is discussed below in greater detail. The time
to return the initial translation documents and obtain
ethical approvals resulted in the greatest variations with
respect to the overall timelines. We found that setting
regular milestones and realistic timelines helped achieve
the required translation objectives. Regular communica-
tion between the CI and collaborators underpinned this
process.
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Our aspiration was to translate the Delphi survey into
Japanese and Korean to enable wider patient participa-
tion from these countries. Due to challenges in identify-
ing collaborators at an early stage, assembling a
translation team and meeting timelines, this could not
be pursued. However, potential participants were invited
to complete the English-language version of the survey.
Recruitment and retention targets COS developers
should consider minimum recruitment targets. Whilst
there is no sample size requirement for Delphi surveys,
the GASTROS protocol initially set a conservative target
of 100 participants in total to be recruited over a period
of 6 to 8 weeks in round 1. However, as interest in the
study and international collaboration grew, it was clear
to see that this target would easily be surpassed. As de-
scribed below, once the survey opened and momentum
began to gather, we witnessed a ‘snowballing’ effect
amongst all three stakeholder groups. We therefore ex-
tended recruitment to 13 weeks by which time new par-
ticipation had plateaued (Fig. 4).
For round 2, an initial retention target of 80% was set
following discussions with members of our study man-
agement group who have extensive knowledge and ex-
perience of COS development. Automated reminder e-
mails were sent out on a weekly basis to participants
and support from professional bodies (in countries
where round 2 responses were slow) was sought to en-
courage completion of the survey. Personalised e-mails
from the CI to professionals were also sent. Using this
strategy, we were able to retain 70% of participants from
round 1 by week 13, by which time no further responses
were being received.
Paper and Internet-based Delphi survey versions The
GASTROS study used both Internet-based and paper
versions of the Delphi survey. The internet-based ver-
sions enabled us to reach participants in nearly 60 coun-
tries, the vast majority of which did not have formal
IWG collaborators. The paper versions (printed versions
of the Internet-based survey which were uploaded elec-
tronically by local collaboration teams) also enabled us
to recruit participants (particularly patients) who either
did not readily have access to the Internet or were not
‘electronically-literate’.
Several platforms exist to enable COS developers to
run Delphi surveys. These include platforms specifically
designed for Delphi surveys and other generic survey
platforms which researchers can use. When considering
multi-language surveys, it is essential to ensure that the
servers on which the surveys are hosted meet the neces-
sary data protection regulations and are accessible par-
ticularly from countries where restrictions to certain
domains exist. Furthermore, COS developers must en-
sure that the platforms used are able to run surveys
using different language scripts and writing systems.
Our group used DelphiManager as it fulfils the re-
quired data protection criteria (as set out by our UK eth-
ical approval) and can work with all language systems
including English, Chinese, Japanese and Korean. Fur-
thermore, the online survey domains are accessible from
countries which commonly restrict access to other
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10 weeks 1 week 29 weeks 3 weeks 1 week
Translation
3
3 weeks 1 week Not
required
3 weeks 1 week
Translation
4
10 weeks 1 week Not
required
3 weeks 1 week
Translation
5
18 weeks 1 week cNot
received
3 weeks 1 week
Translation
6
12 weeks 3 weeks 40 weeks 3 weeks 1 week
Translation
7
2 weeks 1 week 2 weeks 3 weeks 1 week
aThe language versions are anonymised
bThis represented the time the study management group requested collaborators to begin ethical approval applications until IRB approval was received and not
necessarily the time between actual submission of the application and receiving approvals
cEthical approval was not received before the end of round 1 of the Delphi survey. No patients were recruited from this team’s country
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foreign domains. DelphiManager has additional features
which simplified recruitment and completion of the sur-
veys such as being able to send automated reminders to
individuals who had yet to complete all their answers.
Measures to maximise survey recruitment One of the
strengths of our Delphi survey was that it was able to re-
cruit approximately 1000 eligible patients and healthcare
professionals from nearly 60 countries in round 1. From
the study’s inception, the study team recognised the im-
portance of developing a clear networking and dissemin-
ation strategy [5]. We hypothesised that this was
necessary to achieve broad stakeholder participation
both nationally and internationally. Several strategies
were employed to maximise recruitment:
Dissemination of results from previous study stages
The study protocol and findings from previous study
stages [3, 5, 6] were presented at targeted national and
international meetings which were well-attended by po-
tential healthcare worker participants. This was integral
to generating interest and support for our study and en-
sured that participants understood the premise for
GASTROS long before the Delphi survey opened for re-
cruitment. All presentations contained directions to the
study website and social media accounts (see below).
Local recruitment of patients through outpatient
clinics
Ethical approval enabled the study team to recruit pa-
tients directly from outpatient clinics. Our experience
from the UK is that many patients regularly attend pa-
tient support groups and are in contact with other eli-
gible patients. As a result, a snowballing effect resulted
in patients being recruited by patients already within the
study.
Support from stakeholder groups/associations and
national research networks
Support from national and international professional
associations and organisations was sought in the early
stages of the study. Study group members presented the
study objectives at closed executive-level meetings to
gain support and adoption from influential bodies in-
cluding professional associations, patient groups and
charities. Many of these organisations have large mem-
berships (and corresponding electronic mailing lists)
through which the study was advertised. Most of the
groups through whom we sent out invitations followed
up an initial e-mail with a further reminder approxi-
mately 4 weeks later resulting in further recruitment
spikes. Furthermore, the GASTROS study was adopted
onto the National Institute for Health Research (NIHR)
Portfolio (CPMS study ID 38318). This enabled us to ad-
vertise the study to healthcare professionals and patient
support groups within the UK through the national Clin-
ical Research Networks. Our experience suggests that





























































Fig. 4 Cumulative weekly recruitment figures for round 1 of the GASTROS Delphi survey
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in a ‘snow-balling’ effect with subsequent support from
others becoming easier to harness.
Collaborations
Standardising the reporting of outcomes can be
achieved through several approaches. The GASTROS
study aims to identify important outcomes across the
entire spectrum of outcome types. Others have concen-
trated on the reporting of outcomes within a defined
area. For example, the Gastrectomy Complications Con-
sensus Group (GCCG; www.gastrodata.org) has sought
to standardise the reporting of all major post-
gastrectomy complications [16]. Whilst the goals of both
studies are different, both teams have been able to work
closely to minimise duplication of work. In addition, the
GCCG was able to promote recruitment to the GAST
ROS Delphi survey through its membership and respect-
ive networks. Such collaborations will also be vital for
the future development of outcomes research within the
field of gastric cancer surgery.
Personalised e-mails
a. Most of the study management group, study
advisory group and international working group
members have extensive research experience within
the field of gastric cancer surgery. Each member
was asked to promote the study through their
personal research and clinical networks. Bulk e-
mails through professional bodies may be ignored
by potential participants or diverted into ‘spam’ e-
mail folders, hence why this approach was
employed.
b. Corresponding e-mail addresses for authors from
previous trials and protocols included in our sys-
tematic review [3] were identified and personal invi-
tations sent. This captured research-active
healthcare professionals from non-English-speaking
regions where no formal national gastric cancer as-
sociations exist (e.g. Eastern Europe).
Study website, social media and multimedia
a. The study website (http://www.gastrosstudy.org)
provides detailed information about the GASTROS
study aims as well as all its outputs. Prior to the
commencement of the Delphi survey, potential
participants who had heard about the study were
able to register their interest to participate in the
Delphi survey. In the preceding 18 months before
the survey opened, 150 healthcare professionals and
patients had registered.
b. In addition to the study’s Twitter account (https://
twitter.com/GASTROSStudy), members of the
research team posted updates on their personal
Twitter and LinkedIn accounts. Regular study
updates provided potential participants with an
opportunity to better understand the study aims
and keep up to date with its progress. Examination
of analytics revealed that Twitter and LinkedIn
posts in the run-up to and during round 1 of the
survey regularly received over 4000 and 3000 views,
respectively.
c. A series of short videos were produced for the
study. These provided potential participants with an
alternative way to engage with the study. At the
time of writing, these videos had been viewed over
600 times. In addition to an introductory video on
the study, a detailed step-by-step guide to complet-
ing the online Delphi survey was developed. This
created additional content for social media plat-
forms and the GASTROS website which in turn en-
abled the study to maintain a regular online
presence. COS developers may wish to produce dif-
ferent language versions or translate video captions
relatively easily to expand their reach. Additional
COS-related material is already available from the
COMET initiative YouTube site [17] with versions
available in Dutch, Portuguese and Chinese. Work
is underway to develop other language versions as
well.
Whilst advertising the study through these avenues in-
creased the number of recruits, care must also be taken
that potential participants are not ‘bombarded’ with re-
quests to participate in the survey. A small number of
healthcare professionals highlighted that this was an
issue. This coupled with the well-recognised challenges
of ‘survey-fatigue’ may in fact be counter-productive and
result in apathy amongst potential participants.
Ethical approval The requirement for regulatory or eth-
ical approval varied across different regions. In the UK,
the approach to ethical approval has not been consistent;
our group was asked to submit a full application for eth-
ical approval committee consideration, whilst other
groups have been able to gain approval through propor-
tionate review [18]. Each IWG collaborator was respon-
sible for understanding local requirements and applying
for approvals if they were required. They were asked to
enquire about these at the start of their agreement to
participate in the study and applications were made in
parallel to the translation work. Two of our international
collaborating centres did not require ethical approval as
local collaborators did not recruit patients directly from
their clinical practice but instead advertised the study
through local patient groups and recruited healthcare
professionals by advertising through national Societies
and networks. The time taken to complete this process
varied significantly (Table 4) and was largely dependent
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on the frequency of and access to ethics committee
meetings, requirements to amend submitted materials
and delays in final decisions reaching the collaborators.
COS developers should investigate the need for ethical
approval as early as possible to avoid unnecessary delays.
Financial planning Several aspects of undertaking
multi-language Delphi surveys may incur significant
costs depending on which approaches are adopted. COS
developers should take these into account when plan-
ning their studies. These include:
1. Cost of professional translations; this represents the
largest financial burden and has been discussed
above.
2. Ethical and regulatory approvals; some of our non-
UK ethical approval applications required payments
of up to 250 Euros.
3. Use of electronic mailing lists; some stakeholder
groups may charge administration fees to send out
invitations to their membership.
4. Cost of Delphi survey platform; whilst open-access
platforms exist, our group opted to pay to use a
dedicated Delphi survey platform designed for the
development of COS.
5. Statistical and qualitative methods support may be
required when analysing scores in rounds 1 and 2,
depending on the nature of feedback to be given.
Discussion
This study is the first to address the topic of translation
and cross-cultural adaptation in the context of develop-
ing Delphi surveys for COS. We have presented a de-
tailed and easily reproducible approach adapted from
international consensus guidelines which was illustrated
within the context of developing of a COS for gastric
cancer surgery. The approach was accurately replicated
by seven different translation teams within an acceptable
timeframe.
Undertaking ‘international’ Delphi surveys has become
easier as web-based platforms enable wider participation
across different geographical regions. Whether or not
this is warranted depends on the scope and target audi-
ence of the COS in question. As very few pathologies
and interventions are limited to one geographical region,
most clinical trials are undertaken globally. For these tri-
als to include outcomes relevant to all stakeholders, tri-
alists need to be confident that the COS relevant to their
fields are robust. In our example, stakeholders from
Asia, South America and Europe were essential to the
development of the COS as gastric cancer is most preva-
lent in these countries and most trials are undertaken in
these regions. The resulting number of participants from
non-English-speaking nations was significantly higher
than those recruited from English-speaking countries. It
was therefore important that processes used for ensuring
accurate translations were valid and transparently
reported.
Whilst translation of our Delphi survey aimed to
widen participation and broaden the views taken into
consideration, the value of doing so is one which war-
rants further discussion. English is the most commonly
spoken language across the world [19] and is used by
most scientific and healthcare publications. It is there-
fore unsurprising that most ‘international’ COS projects
employing Delphi surveys identified from the COMET
database used an English-only version. The English ver-
sion of our Delphi survey was offered to all participants;
however, most preferred to complete the Delphi in their
native language. This was the case for both patients and
healthcare professionals. Patients were primarily re-
cruited from regions in which surveys were translated to
the local language. Whilst for many the choice of using
a non-English survey version would have been because
they did not speak English, a significant proportion of
bi-lingual healthcare professionals known to the study
team preferred to use a non-English version. One may
argue that this enabled participants to engage more con-
fidently in the process, that their understanding of what
was being asked of them was clearer and that the quality
of their responses may consequently have been better.
Such a high uptake in non-English surveys was not ex-
perienced by three of the four groups who completed
our questionnaire on methodology. This was also
reflected in certain subsets of stakeholder groups which
had access to translated surveys in the GASTROS study.
For example, despite translations being available, no
Spanish patients were recruited to the study. This likely
represented the logistical challenges related to recruit-
ment in non-English-speaking regions which we have
addressed above.
Undoubtedly, achieving high-quality and accurate
translations is resource intensive. The process can take
time if undertaken by healthcare professionals or pose
significant financial costs if study groups employ profes-
sional services. However, restricting a consensus-seeking
process in the development of an international COS to a
single language exposes studies to the risk of excluding
important opinion. It may therefore be argued that for a
COS to be truly regarded as ‘international’, the
consensus-seeking process should be undertaken in the
native language of the participant. Whilst we have dem-
onstrated that non-English Delphi surveys coupled with
local study promotion can increase the number of total
participants, it is not known whether these additional
participants bring a different perspective that has not
already been captured through the English-language ver-
sion. It is likely that there are many additional factors
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which may contribute to the validity of Delphi survey re-
sults (e.g. cultural and geographical differences of partic-
ipants) and COS developers should consider these
carefully during the planning phase. These, along with
other factors, will be the focus of a future analysis by
our study group.
Strengths, limitations and implications for
methodological practice
We have demonstrated that there is no standardised ap-
proach to translation in this field. Each of the four COS
groups reviewed in this paper used different methods to
forward translate and utilised translation teams with differ-
ent member characteristics. A strength of our approach is
that it is based on international consensus guidelines and
was easily reproduced in several culturally diverse regions.
We also provided detailed justifications for each step we
adopted and the pragmatic adaptations which will help
other COS developers, particularly those who may be lim-
ited with respect to financial resources. Our recommenda-
tion is therefore that COS developers should consider
adopting this approach alongside other important consider-
ations to broaden recruitment to their Delphi surveys.
Limitations of our study include that it focussed on
examining the current translation methodology used in
Delphi surveys for COS. It is possible that a broader re-
view of survey translations could have yielded a greater
understanding of current approaches to translations and
methodological aspects that have not been accounted for.
Furthermore, it can be argued that the process by which
the ISPOR-TCA consensus guidelines were adapted to
meet our needs was not undertaken using a formalised ap-
proach [20]. We opted to use an informal approach to
guideline adaptation due to the limited resources available
to us. Furthermore, whilst we have translated our survey
into 7 target languages, this may not have been a sufficient
number needed for a COS. However, it may be argued
that the need for such broad participation of stakeholders
in a Delphi survey is not necessary and that more targeted
recruitment of individuals is sufficient, negating the re-
quirement for the approaches discussed. This is an area
which will be examined as part of our future work.
Conclusion
We present a method of translating Delphi surveys for
use in the development of COS adapted from inter-
national consensus guidelines in the field of outcome
reporting. Consideration of the issues described will im-
prove planning by other COS developers and can be
used to widen international participation from both pa-
tients and healthcare professionals. Ultimately, inter-
nationally developed COS will improve the relevance of
the core set to large-scale clinical trials and therefore
improve healthcare decision-making.
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